Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹272.40
4.90 (1.77%)
High VOLATILITY
As on 10 Jul 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹12.34K Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
29.4
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹155+75.7%
52W High₹281.6-3.3%
Current Price
₹272.40
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹217.92
Upper Circuit₹326.88
Reference Price
₹272.40
Investment Checklist
Ascending Channel on 1D — target ₹280.57
Trend: Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
Volume divergence: Bearish (price up, volume down)
Composite score 43.55 (BUY) with 84.9% confidence
SuperTrend(10,3): Price above SuperTrend (Industry Standard (Swing/Medium-Term))
Technical Analysis
Technical Analysis
Analysis from 2026-07-11
Confidence
85%
Trend
BULLISH
BULLISH
Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
EMA20
260.41
EMA50
239.85
EMA200
207.36
Price Action
MIXED
NEUTRAL
Higher Highs4
Higher Lows5
Lower Highs5
Lower Lows4
Support & Resistance Levels
Resistance (Above)
₹278.80
Support (Below)
₹265.45
₹249.50
₹228.20
₹201.30
₹197.80
Volume Analysis
TrendDECREASING
Change-14.70%
Unusual VolumeNo
Divergence Detected
Bearish (price up, volume down)
Stop Loss Levels
Fixed Risk
1% Risk₹269.68
3% Risk₹264.23
5% Risk₹258.78
7% Risk (Custom)
₹253.33Technical Levels
1x ATR (Volatility)₹260.57
2x ATR (Swing)₹248.74
3x ATR (Trend)₹236.91
Immediate Support₹265.45
Moving Averages
EMA 9 (Short-term)₹267.02
EMA 20 (Medium-term)₹260.41
EMA 50 (Trend)₹239.85
EMA 200 (Long-term)₹207.36
Financials
Financial Analysis
| Metric | Mar '25 | Jun '25 | Sep '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹700.1 Cr | ₹620 Cr | ₹720.4 Cr | ₹754.4 Cr |
| Net Profit | ₹90.5 Cr | ₹58.3 Cr | ₹98.3 Cr | ₹113.2 Cr |
| EPS | — | ₹1.29 | ₹2.17 | ₹2.50 |
| Operating Profit | ₹142.3 Cr | ₹105.8 Cr | ₹166.1 Cr | ₹180.9 Cr |
ROE
15.43%
ROCE
18.49%
Debt/Equity
0.13
Current Ratio
4.62
OPM
23.98%
NPM
15.01%
Peer Comparison
PharmaceuticalsPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹1,935.50 | -0.17% | 40.2 | ₹4.64L Cr large Cap | |
| Divi's Laboratories Limited | ₹6,836.00 | +0.34% | 70.7 | ₹1.81L Cr large Cap | |
| Torrent Pharmaceuticals Limited | ₹4,901.50 | +0.07% | 77.6 | ₹1.66L Cr large Cap | |
| Cipla Limited | ₹1,439.40 | -0.13% | 30.1 | ₹1.16L Cr large Cap | |
| Zydus Lifesciences Limited | ₹1,150.80 | -0.71% | 22.8 | ₹1.16L Cr large Cap | |
| Lupin Limited | ₹2,496.30 | -0.28% | 21.3 | ₹1.14L Cr mid Cap | |
| Mankind Pharma Limited | ₹2,525.10 | -0.27% | 54.1 | ₹1.04L Cr mid Cap | |
| Dr. Reddy's Laboratories Limited | ₹1,244.30 | -1.99% | 25.1 | ₹1.04L Cr large Cap | |
| Aurobindo Pharma Limited | ₹1,564.70 | -1.43% | 25.7 | ₹90.88K Cr mid Cap | |
| Laurus Labs Limited | ₹1,537.80 | +2.02% | 93.4 | ₹83.02K Cr mid Cap | |
| Marksans Pharma Limited | ₹272.40 | -1.77% | 29.4 | ₹12.34K Cr small Cap |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 01 Aug 2025 | Dividend - Re 0.80 Per Share | DIVIDEND |
| 17 Sept 2024 | Dividend - Rs 0.60 Per Share | DIVIDEND |
| 07 Jun 2023 | Dividend - Re 0.50 Per Share | DIVIDEND |
| 19 Aug 2022 | Annual General Meeting/Dividend - Rs 0.25 Per Share | AGM |
| 15 Sept 2021 | Annual General Meeting/Dividend - Rs 0.25 Per Share | AGM |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for MARKSANS
View AllNEWS
neutral
Business Standard - Markets 3d ago
Marksans Pharma inks deal to acquire ABCnow GmbH
For a total consideration of 892,384
MARKSANSTOTALHealthcareServices
positive
ET Markets - Industry 3d ago
Marksans Pharma to acquire Germany-based ABCnow GmbH
Marksans Pharma announced its definitive agreement to acquire ABCnow GmbH. This German pharmaceutical distributor will be purchased for nearly ten crore rupees. The acquisition aims to expand Marksans' European market presence and distribution capabilities. It will allow the company to market its products directly within the EU. This strategic move is anticipated to conclude by July 2026.
MARKSANSHealthcare
NEWS
positive
Business Standard - Markets 3d ago
Marksans Pharma rises after acquiring 100% stake in ABCnow GmbH
Marksans Pharma added 3.77% to Rs 270.90 after the company said that it has entered into a definitive agreement to acquire 100% of the share capital of Germany-based ABCnow GmbH.
AKCAPITCPCAPMARKSANSFinancial ServicesHealthcare